| 1. | 7senza6 | |
| 2. | GeniusByTrade | |
| 3. | cspmedia | |
| 4. | blackopsstreet | |
| 5. | TradeChem |
Top Board Researchers
These are the top researchers based on quality of posts as voted by board members. Typically they know their stuff and are a great
way to catch up on what the company is all about.
HOW DO I BECOME ONE?
Just do great research! As other members approve of your posts, you earn points that move you up the ranks.| 1. | 7senza6 02/09/2018 Risk Assessment Committee (PRAC) |
| 2. | zhiggeOS29 10/18/2017 The Biggest Loser: Allergan's Patent Troubles |
| 3. | GeniusByTrade 01/10/2018 Allergan Is Set Up for Success in 2018, UBS Says |
| 4. | cspmedia 02/06/2018 Announces Positive Top Line Phase 3 Results for Ubrogepant - an Oral CGRP Receptor Antagonist for the Acute T… |
| 5. | nsinaver 07/19/2018 Releases 'two positive clinical trials, SEQUOIA and CEDAR for abicipar |
| 6. | GeniusByTrade 02/28/2018 News out here |
| 7. | blackopsstreet 04/02/2018 Report of potential Womens health unit sale; could be a +$5 billion deal |
| 8. | TradeChem 09/10/2017 Reversing on the chart, possible cup and handle |
| 9. | blackopsstreet 12/01/2017 dont remind me |
| 10. | 7senza6 02/06/2018 Beats EPS estimates by $0.12 and beats on revenues |
NEW since the last time you visited this board.
Currently a TOP 10 POST for this board.
Currently a TOP 5 RESEARCHER for this board.
Specific post has replies to it.
A Researcher you are currently FOLLOWING
Other Researchers rate this post HIGH
Other Researchers rate this post LOW
Allergan plc.
- AGN
- Public Stock Message Board
Filtering by:
-
To use your chart in a post, click the
icon above the chart. From there you can get the chart link or download the image.